Stock CDXC CHROMADEX CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Chromadex Corp OTC Bulletin Board

Equities

CDXC

US1710771007

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Chromadex Corp
May. 08 Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024
May. 08 Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M
MT
ChromaDex Corporation Reports First Quarter 2024 Financial Results
BU
ChromaDex Corporation Reiterates Earnings Guidance for the Full Year of 2024
CI
ChromaDex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ChromaDex's NIAGEN, the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar Cellular Nutrition Cellular Energy Supplement
AQ
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
BU
Chromadex Corp. Announces an Ingredient Partnership with Solgar
CI
ChromaDex Announces Nationwide Launch of Tru Niagen at The Vitamin Shoppe
AQ
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
BU
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen at Sprouts Farmers Market
AQ
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
BU
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
BU
Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market
CI
Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating
MT
ChromaDex Announces Tru Niagen is Now Third-Party Verified through the Alkemist Assured Transparency Program
AQ
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
BU
ChromaDex : March 2024 Investor Presentation
PU
HC Wainwright Adjusts Price Target on ChromaDex to $6 From $5, Maintains Buy Rating
MT
Transcript : ChromaDex Corporation, Q4 2023 Earnings Call, Mar 06, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDXC Stock
  4. CDXC Stock
  5. News Chromadex Corp
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW